Perbedaan Lippo General Insurance Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Lippo General Insurance Tbk. diperdagangkan di Rp670 (kapitalisasi pasar 2,03 T, volume 24 jam 3,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Lippo General Insurance Tbk. jauh lebih besar — sekitar 12,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (96,7 rb vs 3,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPGI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 2,03 T | 167,37 M |
Volume | 3,5 rb | 96,7 rb |
Lot | 35 | 967 |
Perputaran | 2,31 jt | 23,82 jt |
Harga Rata-rata | 659,14 | 246,34 |
Nilai Transaksi | 2,31 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 675 | 248 |
Volume Ekuilibrium Indikatif | 100 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lippo General Insurance Tbk (the Company) was established and domiciled in Surabaya based on Notarial Deed No. 1 of Adasiah Harahap, S.H., notary in Jakarta, dated September 6, 1963, under the name of PT Asuransi Brawidjaja and was changed to PT Maskapai Asuransi Marga Pusaka based onNotarial Deed No. 46 of Misahardi Wilamarta, S.H., notary in Jakarta, subtitute notary of Adasiah Harahap, S.H., notary in Jakarta.
Selengkapnya di halaman LPGI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →